IP Library Granted Patent US 11,104,882
Granted Patent B2
US 11,104,882 · App. 17/013,379 · Granted Aug 31, 2021

System and method for extraction and cryopreservation of bone marrow

Inventors: Erik John Woods (Carmel, IN); Brian H. Johnstone (Fishers, IN); Dongsheng Gu (Indianapolis, IN); Aubrey Marie Sherry (Carmel, IN); Kelsey Gwen Musall (Avon, IN); John R. Woods (Indianapolis, IN); James Hardin (Columbia, SC); Alan Hooks (Commerce City, CO)
Assignee: Ossium Health, Inc.
C12N5/0663A01N1/0221A61B17/1611A61B2017/00831
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,104,882
App. No.
17/013,379
Granted
Aug 31, 2021
Kind
B2
Abstract

Methods are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation and for obtaining desired cells from cryopreserved and fresh bone marrow.

Claims (25)

1. A method for high-yield recovery of stem cells from cadaver bone or cadaver bone fragments, the method comprising:

(a) obtaining cadaver bone or cadaver bone fragments;

(b) processing the bone or bone fragments to extract bone marrow cells;

(c) obtaining a reduced density solution mixture of a hydrophilic copolymer of sucrose and epichlorohydrin at density 1.077 g/mL, mixed with an electrolyte medium, wherein the reduced density solution mixture provides a density gradient of 1.063-1.052 g/m;

(d) combining the extracted bone marrow cells with the reduced density solution mixture;

(e) centrifuging the extracted bone marrow cells, thereby separating out buffy coat cells comprising stem cells; and

(f) harvesting the buffy coat cells, thereby recovering stem cells comprising hematopoietic stem cells and/or mesenchymal stem cells.

2. The method of claim 1 , wherein after centrifuging in step (e), the buffy coat cells are located in the density gradient at a density of about 1.063 g/ml.

3. The method of claim 1 wherein the centrifuging occurs for about 30 minutes at 400 g.

4. The method of claim 1 , wherein the centrifuging occurs for about 5 minutes at 400 g.

5. The method of claim 1 , wherein the cadaver bone or cadaver bone fragment has not been cryopreserved prior to processing in step (b).

6. The method of claim 1 , wherein the purity of recovered stem cells is about 90% or a higher purity.

7. The method of claim 1 , wherein the viability of recovered stem cells is about 90% or a higher viability.

8. The method of claim 1 , wherein the processing in step (b) comprises grinding the cadaver bone fragments to obtain ground cadaver bone, wherein grinding uses a bone grinder in the presence of a grinding medium, and, optionally, further comprises dividing cadaver bone into cadaver bone fragments.

9. The method of claim 8 , wherein the grinding medium comprises two or more of enzymes that cleave DNA and RNA, human serum albumin (HSA) heparin, and an electrolyte medium.

10. The method of claim 8 , wherein the grinding medium promotes extraction of bone marrow cells from the ground cadaver bone.

11. The method of claim 10 , wherein the ground cadaver bone is captured on a filter or sieve and a filtrate that passes thru the filter or sieve comprises the extracted bone marrow cells.

12. The method of claim 1 , further comprising after step (f), a step of washing the harvested buffy coat cells for subsequent use or further processing.

13. The method of claim 12 , wherein the washing includes contacting the cells with phosphate-buffered saline (PBS) containing human serum albumin (HSA) and ethylenediaminetetraacetic acid (EDTA) or with PBS alone.

14. The method of claim 1 , further comprising a step of performing a separation method that isolates CD34+ cells from the recovered stem cells.

15. The method of claim 1 , wherein the cadaver bone or the cadaver bone fragments are derived from a vertebral body, an ileum, or a combination thereof.

16. The method of claim 1 , wherein the cadaver bone or cadaver bone fragments are derived from a plurality of cadaver bones from the same donor.

17. The method of claim 1 , wherein the hematopoietic stem cells are CD34+ cells.

18. The method of claim 1 , wherein the density gradient provides a recovered stem cell population having higher purity CD34+ cells with higher viability than a recovered stem cell population obtained from a conventional hydrophilic copolymer of sucrose and epichlorohydrin gradient.

19. The method of claim 1 , wherein the cadaver bone or cadaver bone fragments have been exposed to a hypothermic temperature.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 17, 2023
From: OSSIUM HEALTH, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065257/0134 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2020
From: WOODS, ERIK J.; JOHNSTONE, BRIAN H.; GU, DONGSHENG; SHERRY, AUBREY M.; MUSALL, KELSEY G.; WOODS, JOHN R.; HARDIN, JAMES; HOOKS, ALAN
To: OSSIUM HEALTH, INC.
Reel/Frame 053748/0068 →
Continuity (4)
Continuation 16734713 · Jan 6, 2020
Provisional Application 62938480 · Nov 21, 2019
Provisional Application 62834087 · Apr 15, 2019
Related Publication 20200399604A1 · Dec 24, 2020
Cited By (3)
US 12,268,207 US 12,680,079 US 12,698,478